Lilly is releasing vials of its weight loss drug Zepbound for as low as $399 a month

The Eli Lilly Company said Tuesday it has begun selling vials of the lowest starting dose of its popular weight-loss drug Zepbound in the United States at $399 for a one-month supply through its direct-to-consumer website to increase its availability in the market.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG